Skip to main content

Corbus Pharmaceuticals Holdings, Inc.

CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001595097

In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.

13F holders, Q1 2021

Institutional positions in Corbus Pharmaceuticals Holdings, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
107
No complete 13F data for Q4 2020
Shares held
44.0M
No complete 13F data for Q4 2020
Total value
$86.2M
No complete 13F data for Q4 2020

Holders and value by quarter

Institutions reporting CRBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2021: 107 institutions
Q1 2021: 107 institutionsQ2 2021: 99 institutionsQ3 2021: 87 institutionsQ4 2021: 83 institutionsQ1 2022: 73 institutionsQ2 2022: 71 institutionsQ3 2022: 65 institutionsQ4 2022: 63 institutionsQ1 2023: 30 institutionsQ2 2023: 28 institutionsQ3 2023: 27 institutionsQ4 2023: 34 institutionsQ1 2024: 82 institutionsQ2 2024: 107 institutionsQ3 2024: 107 institutionsQ4 2024: 99 institutionsQ1 2025: 86 institutionsQ2 2025: 80 institutionsQ3 2025: 81 institutionsQ4 2025: 101 institutionsQ1 2026: 108 institutionsQ2 2026: 107 institutions
Value heldQ1 2021: $86.2M
Q1 2021: $86.2MQ2 2021: $91.0MQ3 2021: $45.6MQ4 2021: $27.2MQ1 2022: $19.7MQ2 2022: $8.04MQ3 2022: $3.86MQ4 2022: $1.31MQ1 2023: $5.26MQ2 2023: $5.80MQ3 2023: $5.01MQ4 2023: $4.53MQ1 2024: $334.7MQ2 2024: $486.1MQ3 2024: $243.1MQ4 2024: $129.3MQ1 2025: $55.4MQ2 2025: $62.5MQ3 2025: $111.5MQ4 2025: $108.4MQ1 2026: $121.2MQ2 2026: $129.1M
Institutions holding CRBP and their total value by quarter
QuarterHoldersValue
Q2 2026107$129.1M
Q1 2026108$121.2M
Q4 2025101$108.4M
Q3 202581$111.5M
Q2 202580$62.5M
Q1 202586$55.4M
Q4 202499$129.3M
Q3 2024107$243.1M
Q2 2024107$486.1M
Q1 202482$334.7M
Q4 202334$4.53M
Q3 202327$5.01M
Q2 202328$5.80M
Q1 202330$5.26M
Q4 202263$1.31M
Q3 202265$3.86M
Q2 202271$8.04M
Q1 202273$19.7M
Q4 202183$27.2M
Q3 202187$45.6M
Q2 202199$91.0M
Q1 2021107$86.2M

Institutions, Q1 2021

Shares, value and share of portfolio for each institution holding Corbus Pharmaceuticals Holdings, Inc..

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.

Institutions holding CRBP in Q1 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc3,803,777$7.49M0.00%––
Morgan Stanley3,961,808$7.80M0.00%––
Knoll Capital Management, LLC5,045,870$9.94M6.48%––
BlackRock Inc.5,673,664$11.2M0.00%––
ETF Managers Group, LLC6,020,395$11.9M0.21%––
Nuveen Asset Management, LLC253,115––––
Trust Co99––––